✦ LIBER ✦
Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab
✍ Scribed by Dimitri Flieger; Sabine Hainke; Wolfgang Fischbach
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 66 KB
- Volume
- 85
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.